Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18832245 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: Maraviroc (UK-427,857);   Drug: Optimized Background Therapy;   Drug: Placebo
2 Completed
Has Results
Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: Maraviroc (UK-427,857);   Drug: optimized background therapy

Indicates status has not been verified in more than two years